ALB SOLUTIONS

Lobbying for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. · Pharmaceutical company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Connecticut · House · Senate · $40,000.00 income · posted Jul 16, 2025

Lobbying activity 1

Pharmacy

Issues related to regulatory and legislative developments regarding biosimilars and prescription digital therapeutics.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.